Bringing diabetes treatment into focus

Quantitative imaging of beta cell mass may help with treatment for type 1 diabetes

2026-03-12

(Press-News.org) Kyoto, Japan -- In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of the disease, so preserving or restoring beta cell mass is a central treatment goal.

New therapies aimed at preserving or increasing beta cell mass are advancing rapidly, but a noninvasive, direct measurement of this mass, and how much has been preserved or restored in interventions, is still lacking in routine clinical settings. Assessment of beta cell loss has largely relied on indirect blood-based markers that can be influenced by glucose conditions, making it difficult to assess as the condition advances.

This motivated a team of researchers at Kyoto University to evaluate an 18F-labeled PET tracer targeting the GLP-1 receptor, which they hypothesized could provide a noninvasive assessment of residual beta cell mass.

"Our study was driven by a key gap in type 1 diabetes research and care," says first author Kentaro Sakaki. "We hope this approach can help fill that gap by providing an objective readout for therapeutic evaluation."

The research team conducted a prospective study at Kyoto University Hospital, first intravenously administering [18F]FB(ePEG12)12-exendin-4, a GLP-1 receptor-targeted PET tracer, to adults with type 1 diabetes, who then underwent PET and CT imaging. The researchers then used standardized PET measures to quantify the pancreatic uptake, comparing it with data from participants without diabetes. Finally, the team examined the imaging results in relation to clinical and laboratory measures linked to beta cell function and glucose levels.

The results revealed that the pancreatic imaging measurement was lower in participants with type 1 diabetes than in participants without diabetes, and that this measurement was inversely related to hemoglobin A1c, a measure of average blood glucose levels over the previous two to three months, and the total daily insulin dose used for treatment. The researchers also observed no serious side effects among the participants.

Larger and longitudinal studies, and studies with more diverse participants, are needed to confirm the utility of the PET tracer in measuring beta cell mass. But if substantiated in future studies, beta cell-targeted PET/CT could complement existing assessments by providing a direct, imaging-based readout of residual beta cell mass.

This method may potentially help define stages of the disease, track changes over time, and offer an objective endpoint for clinical studies that aim to preserve or restore beta cells. It may be especially useful when beta cell function temporarily declines and does not mirror residual beta cell mass.

"Many decisions in type 1 diabetes treatment would benefit from a clearer picture of how much beta cell mass remains," says team leader Takaaki Murakami. "Our findings suggest that this tracer may provide a noninvasive, quantitative readout that could support disease staging and treatment monitoring."

###

The paper "Quantitative β-cell mass imaging redefines disease staging and glycemic control in type 1 diabetes" appeared on 12 March 2026 in Diabetes, with doi: 10.2337/db25-1127

About Kyoto University

Kyoto University is one of Japan and Asia's premier research institutions, founded in 1897 and responsible for producing numerous Nobel laureates and winners of other prestigious international prizes. A broad curriculum across the arts and sciences at undergraduate and graduate levels complements several research centers, facilities, and offices around Japan and the world. For more information, please see: http://www.kyoto-u.ac.jp/en

END

ELSE PRESS RELEASES FROM THIS DATE:

Iowa-led research team names, describes new crocodile that hunted iconic Lucy’s species

2026-03-12

More than 3 million years ago, when our ancient ancestors embodied by the iconic Lucy were roaming the African landscape, they would have feared a big, bad crocodile with a prominent lump on its head, patiently lurking in rivers and lakes to attack them. That crocodile is a new species, a research team led by the University of Iowa has determined. In a new study, published on March 12 in the Journal of Systematic Palaeontology, the researchers describe the species and give it a name: Crocodylus lucivenator, or Lucy's hunter. The name seems quite appropriate. The ancient reptile lived between 3.4 million to 3 million years ago, overlapping the time period and ...

One-third of Americans making financial trade-offs to pay for healthcare

2026-03-12

WASHINGTON, D.C. — March 12, 2026 — About one in three U.S. adults, the equivalent of over 82 million Americans, report having made at least one daily life trade-off in the past year to pay for healthcare expenses, according to new research released today from the West Health-Gallup Center on Healthcare in America. The most common actions taken are prescription rationing and non-adherence (15%) and borrowing money (15%). Unsurprisingly, the financial strain is most prevalent among households earning ...

Researchers clarify how ketogenic diets treat epilepsy, guiding future therapy development

2026-03-12

Published today in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ketogenic diets reduce seizures in people with epilepsy. The paper brings together insights from both laboratory discoveries and real‑world patient outcomes, showing that ketogenic diets do far more than reduce seizures. The review outlines how these strict high-fat, low carbohydrate diets strengthen the brain’s energy systems, reduce inflammation and protect neurons - providing therapeutic benefits that many current medications are not yet able to achieve. “For ...

PsyMetRiC – a new tool to predict physical health risks in young people with psychosis

2026-03-12

PsyMetRiC is the first validated cardiometabolic prediction tool specifically tailored for this group, developed into a healthcare professional-facing web application PsyMetRiC predicts risks of outcome measures that are meaningful in clinical practice, and desired by patients It is among the first prediction tools in psychiatry to be certified by the MHRA for use in real-world healthcare A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes. The algorithms behind PsyMetRiC have been specifically tailored for young ...

Island birds reveal surprising link between immunity and gut bacteria

2026-03-12

Scientists at the University of East Anglia (UK) have uncovered a hidden link between gut health and the immune system – all thanks to a tiny island bird. Researchers studied the Seychelles warbler, a small songbird found on Cousin Island in the Seychelles. They collected the birds’ poo to analyse their gut bacteria – and found that their immune genes influence which gut microbes thrive. They say their work sheds light on how animal immune systems and communities of beneficial gut bacteria evolve together - including in humans. Senior researcher ...

Research presented at international urology conference in London shows how far prostate cancer screening has come

2026-03-12

Research presented at international urology conference in London shows how far prostate cancer screening has come Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026. Highlights of some of the key advances in the prostate cancer screening field are detailed below. Tobias Nordström is a clinical urologist and Associate Professor at the Karolinska Institute, Sweden and a member of the EAU Scientific Congress Office. He said: ...

Further evidence of developmental risks linked to epilepsy drugs in pregnancy

2026-03-11

Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk for several other antiseizure drugs including levetiracetam and lamotrigine. However, the researchers say continued monitoring of the few signals - possible associations between a medicine and an unintended side effect - that emerged (eg, for zonisamide) will be important. Antiseizure drugs are ...

Cosmetic procedures need tighter regulation to reduce harm, argue experts

2026-03-11

The rise in invasive cosmetic procedures demands tighter regulation, better consumer protection, and greater awareness to protect patient safety and reduce cosmetic tourism, argue experts in The BMJ today. The global market for cosmetic procedures is growing rapidly and is projected to exceed $180bn by 2033, note Danielle Griffiths at the University of Liverpool and colleagues. Invasive cosmetic procedures typically involve the insertion of instruments or equipment into the body (eg, tummy tucks and breast augmentation), while non-surgical procedures are minimally invasive (eg, botox and dermal fillers), they ...

How chaos theory could turn every NHS scan into its own fortress

2026-03-11

Fresh research from the University of East Anglia (UEA) could transform how the NHS protects patients’ medical images from cyber‑attacks. Computer scientists have developed a breakthrough way to encrypt medical images such as X‑rays, CT scans and MRIs, keeping them secure even if hospital networks are breached. Medical imaging systems have been repeatedly identified as weak points, with many relying on legacy protocols that were never designed to be exposed to the internet, making image‑level encryption an urgent priority. Developed ...

Vaccine gaps rooted in structural forces, not just personal choices: SFU study

2026-03-11

A Simon Fraser University study is pushing back against the “easy narrative” that not getting vaccinated is entirely a personal decision. Rather, vaccine hesitancy in Canada comes down to significant cultural, administrative, institutional and governance barrers that reinforce mistrust and create inequitable access to vaccines, say SFU researchers. Published in the journal Vaccine, the study analyzed 41 peer‑reviewed papers to map how barriers emerge across four areas: cultural and community norms, governance structures, laws and budgets, and institutional design. Key ...

3D-printed robotic rattlesnake triggers an avoidance response in zoo animals, especially species which share their distribution with rattlers in nature

Bringing diabetes treatment into focus

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: